A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel

Yi Long Wu; Chang Li Wang; Mei Lin Liao; Zhong Zhen Guan; Chen Yan Gao; Shun Lu; Ming Fang Zhao; Jie Wang; Xiao Qing Liu; Jin Ji Yang; Jun Liang; Wei Min Mao; Bao Hui Han; Xu Chao Zhang; Yong Song; Ji Feng Feng; Sheng Lin Ma; Gang Wu; Cai Cun Zhou; Ke Neng Chen; Ying Cheng; Yong He; Chun Chen; Qun Wang; Ji Zhen Lin; Bo Zhu; Yun Peng Liu; Yi Hu; Gui Bin Qiao; Qing Zhou; Qi Bin Song; Nan Wu; Lin Wu; Cheng Huang; Xiao Long Fu; Jian Ping Xiong; Jie Hu; Cheng Ping Hu; Jian Hua Chang; Qiong Zhao; Jun Zhao; Peng Hui Zhou; Zhi Yong Ma; Yuan Chen; He Long Zhang; Fan Yang; Jian Jun Wang; Yue Yin Pan; Xue Ning Yang; Yun Fan; Zhe Liu; Wen Fan; Nong Yang; Yan Fang Guan; Hao Sun; Wen Zhao Zhong

doi:10.21037/tlcr.2018.04.15

A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel

Yi Long Wu, Chang Li Wang, Mei Lin Liao, Zhong Zhen Guan, Chen Yan Gao, Shun Lu, Ming Fang Zhao, Jie Wang, Xiao Qing Liu, Jin Ji Yang, Jun Liang, Wei Min Mao, Bao Hui Han, Xu Chao Zhang, Yong Song, Ji Feng Feng, Sheng Lin Ma, Gang Wu, Cai Cun Zhou, Ke Neng ChenYing Cheng, Yong He, Chun Chen, Qun Wang, Ji Zhen Lin, Bo Zhu, Yun Peng Liu, Yi Hu, Gui Bin Qiao, Qing Zhou, Qi Bin Song, Nan Wu, Lin Wu, Cheng Huang, Xiao Long Fu, Jian Ping Xiong, Jie Hu, Cheng Ping Hu, Jian Hua Chang, Qiong Zhao, Jun Zhao, Peng Hui Zhou, Zhi Yong Ma, Yuan Chen, He Long Zhang, Fan Yang, Jian Jun Wang, Yue Yin Pan, Xue Ning Yang, Yun Fan, Zhe Liu, Wen Fan, Nong Yang, Yan Fang Guan, Hao Sun, Wen Zhao Zhong

Otolaryngology

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

The notable clinical success of cancer immunotherapy using checkpoint blockade suggests that it is likely to form the foundation of curative therapy for many malignancies. However, checkpoint blockades do not achieve sustained clinical response in most patients and thus amounts of problems needed to be figured out. Regarding these challenges, the 2017 Chinese Lung Cancer Summit expert panel organized a forum on the 14th Chinese Lung Cancer Summit to formally discuss these controversies. Five consensuses finally were reached to guide the application of checkpoint blockades.

Original language	English (US)
Pages (from-to)	428-436
Number of pages	9
Journal	Translational Lung Cancer Research
Volume	7
Issue number	3
DOIs	https://doi.org/10.21037/tlcr.2018.04.15
State	Published - Jun 1 2018

Bibliographical note

Publisher Copyright:
© Translational lung cancer research.

Keywords

Consensus
Immunotherapy
Lung cancer

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.21037/tlcr.2018.04.15

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037958

OpenUrl availability

Full text

Cite this

Wu, Y. L., Wang, C. L., Liao, M. L., Guan, Z. Z., Gao, C. Y., Lu, S., Zhao, M. F., Wang, J., Liu, X. Q., Yang, J. J., Liang, J., Mao, W. M., Han, B. H., Zhang, X. C., Song, Y., Feng, J. F., Ma, S. L., Wu, G., Zhou, C. C., ... Zhong, W. Z. (2018). A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel. Translational Lung Cancer Research, 7(3), 428-436. https://doi.org/10.21037/tlcr.2018.04.15

Wu, YL, Wang, CL, Liao, ML, Guan, ZZ, Gao, CY, Lu, S, Zhao, MF, Wang, J, Liu, XQ, Yang, JJ, Liang, J, Mao, WM, Han, BH, Zhang, XC, Song, Y, Feng, JF, Ma, SL, Wu, G, Zhou, CC, Chen, KN, Cheng, Y, He, Y, Chen, C, Wang, Q, Lin, JZ, Zhu, B, Liu, YP, Hu, Y, Qiao, GB, Zhou, Q, Song, QB, Wu, N, Wu, L, Huang, C, Fu, XL, Xiong, JP, Hu, J, Hu, CP, Chang, JH, Zhao, Q, Zhao, J, Zhou, PH, Ma, ZY, Chen, Y, Zhang, HL, Yang, F, Wang, JJ, Pan, YY, Yang, XN, Fan, Y, Liu, Z, Fan, W, Yang, N, Guan, YF, Sun, H & Zhong, WZ 2018, 'A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel', Translational Lung Cancer Research, vol. 7, no. 3, pp. 428-436. https://doi.org/10.21037/tlcr.2018.04.15

@article{2e54ae70fcb3431cb94826f3d7a10c50,

title = "A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel",

abstract = "The notable clinical success of cancer immunotherapy using checkpoint blockade suggests that it is likely to form the foundation of curative therapy for many malignancies. However, checkpoint blockades do not achieve sustained clinical response in most patients and thus amounts of problems needed to be figured out. Regarding these challenges, the 2017 Chinese Lung Cancer Summit expert panel organized a forum on the 14th Chinese Lung Cancer Summit to formally discuss these controversies. Five consensuses finally were reached to guide the application of checkpoint blockades.",

keywords = "Consensus, Immunotherapy, Lung cancer",

author = "Wu, {Yi Long} and Wang, {Chang Li} and Liao, {Mei Lin} and Guan, {Zhong Zhen} and Gao, {Chen Yan} and Shun Lu and Zhao, {Ming Fang} and Jie Wang and Liu, {Xiao Qing} and Yang, {Jin Ji} and Jun Liang and Mao, {Wei Min} and Han, {Bao Hui} and Zhang, {Xu Chao} and Yong Song and Feng, {Ji Feng} and Ma, {Sheng Lin} and Gang Wu and Zhou, {Cai Cun} and Chen, {Ke Neng} and Ying Cheng and Yong He and Chun Chen and Qun Wang and Lin, {Ji Zhen} and Bo Zhu and Liu, {Yun Peng} and Yi Hu and Qiao, {Gui Bin} and Qing Zhou and Song, {Qi Bin} and Nan Wu and Lin Wu and Cheng Huang and Fu, {Xiao Long} and Xiong, {Jian Ping} and Jie Hu and Hu, {Cheng Ping} and Chang, {Jian Hua} and Qiong Zhao and Jun Zhao and Zhou, {Peng Hui} and Ma, {Zhi Yong} and Yuan Chen and Zhang, {He Long} and Fan Yang and Wang, {Jian Jun} and Pan, {Yue Yin} and Yang, {Xue Ning} and Yun Fan and Zhe Liu and Wen Fan and Nong Yang and Guan, {Yan Fang} and Hao Sun and Zhong, {Wen Zhao}",

note = "Publisher Copyright: {\textcopyright} Translational lung cancer research.",

year = "2018",

month = jun,

day = "1",

doi = "10.21037/tlcr.2018.04.15",

language = "English (US)",

volume = "7",

pages = "428--436",

journal = "Translational Lung Cancer Research",

issn = "2218-6751",

publisher = "Society for Translational Medicine (STM)",

number = "3",

}

TY - JOUR

T1 - A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel

AU - Wu, Yi Long

AU - Wang, Chang Li

AU - Liao, Mei Lin

AU - Guan, Zhong Zhen

AU - Gao, Chen Yan

AU - Lu, Shun

AU - Zhao, Ming Fang

AU - Wang, Jie

AU - Liu, Xiao Qing

AU - Yang, Jin Ji

AU - Liang, Jun

AU - Mao, Wei Min

AU - Han, Bao Hui

AU - Zhang, Xu Chao

AU - Song, Yong

AU - Feng, Ji Feng

AU - Ma, Sheng Lin

AU - Wu, Gang

AU - Zhou, Cai Cun

AU - Chen, Ke Neng

AU - Cheng, Ying

AU - He, Yong

AU - Chen, Chun

AU - Wang, Qun

AU - Lin, Ji Zhen

AU - Zhu, Bo

AU - Liu, Yun Peng

AU - Hu, Yi

AU - Qiao, Gui Bin

AU - Zhou, Qing

AU - Song, Qi Bin

AU - Wu, Nan

AU - Wu, Lin

AU - Huang, Cheng

AU - Fu, Xiao Long

AU - Xiong, Jian Ping

AU - Hu, Jie

AU - Hu, Cheng Ping

AU - Chang, Jian Hua

AU - Zhao, Qiong

AU - Zhao, Jun

AU - Zhou, Peng Hui

AU - Ma, Zhi Yong

AU - Chen, Yuan

AU - Zhang, He Long

AU - Yang, Fan

AU - Wang, Jian Jun

AU - Pan, Yue Yin

AU - Yang, Xue Ning

AU - Fan, Yun

AU - Liu, Zhe

AU - Fan, Wen

AU - Yang, Nong

AU - Guan, Yan Fang

AU - Sun, Hao

AU - Zhong, Wen Zhao

PY - 2018/6/1

Y1 - 2018/6/1

N2 - The notable clinical success of cancer immunotherapy using checkpoint blockade suggests that it is likely to form the foundation of curative therapy for many malignancies. However, checkpoint blockades do not achieve sustained clinical response in most patients and thus amounts of problems needed to be figured out. Regarding these challenges, the 2017 Chinese Lung Cancer Summit expert panel organized a forum on the 14th Chinese Lung Cancer Summit to formally discuss these controversies. Five consensuses finally were reached to guide the application of checkpoint blockades.

AB - The notable clinical success of cancer immunotherapy using checkpoint blockade suggests that it is likely to form the foundation of curative therapy for many malignancies. However, checkpoint blockades do not achieve sustained clinical response in most patients and thus amounts of problems needed to be figured out. Regarding these challenges, the 2017 Chinese Lung Cancer Summit expert panel organized a forum on the 14th Chinese Lung Cancer Summit to formally discuss these controversies. Five consensuses finally were reached to guide the application of checkpoint blockades.

KW - Consensus

KW - Immunotherapy

KW - Lung cancer

UR - http://www.scopus.com/inward/record.url?scp=85048662998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048662998&partnerID=8YFLogxK

U2 - 10.21037/tlcr.2018.04.15

DO - 10.21037/tlcr.2018.04.15

M3 - Article

C2 - 30050780

AN - SCOPUS:85048662998

SN - 2218-6751

VL - 7

SP - 428

EP - 436

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

IS - 3

ER -

A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this